# A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts

> **NCT02338336** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nowarta Biopharma Inc** · enrollment: 54 (actual)

## Conditions studied

- Plantar Warts

## Interventions

- **DRUG:** Nowarta110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02338336
- **Lead sponsor:** Nowarta Biopharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338336, "A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02338336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*